
<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/themes/root/assets/xsl/rss.xsl"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>نتائج لـ (( decrease therapeutic options ) OR ( great therapeutic options ))</title>
    <description>يعرض 1 - 7 نتائج من 7</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;lookfor=%28%28+decrease+therapeutic+options+%29+OR+%28+great+therapeutic+options+%29%29&amp;type=AllFields&amp;lng=ar</link>
    <opensearch:totalResults>7</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="%28%28%20decrease%20therapeutic%20options%20%29%20OR%20%28%20great%20therapeutic%20options%20%29%29" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" title="اذهب إلى الصفحة الأولى" href="https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;lookfor=%28%28+decrease+therapeutic+options+%29+OR+%28+great+therapeutic+options+%29%29&amp;type=AllFields&amp;lng=ar"/>
    <atom:link rel="last" type="application/rss+xml" title="اذهب إلى الصفحة الأخيرة" href="https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;lookfor=%28%28+decrease+therapeutic+options+%29+OR+%28+great+therapeutic+options+%29%29&amp;type=AllFields&amp;lng=ar"/>
    <atom:link rel="self" type="application/rss+xml" href="https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;lookfor=%28%28+decrease+therapeutic+options+%29+OR+%28+great+therapeutic+options+%29%29&amp;type=AllFields&amp;lng=ar"/>
    <item>
      <title>1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH</title>
      <pubDate>Fri, 01 Jan 2010 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_2abf1b55c1a3d17adcd016075e5a2823</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_2abf1b55c1a3d17adcd016075e5a2823</guid>
      <author>Elhilali, Mostafa</author>
      <dc:format>article</dc:format>
      <dc:date>2010</dc:date>
      <dc:creator>Elhilali, Mostafa</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Arginine Deprivation in AML Cells Induces Ferroptosis, a Type of Autophagy-Mediated Cell Death</title>
      <pubDate>Sun, 01 Jan 2023 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_56c3dd1b18e078bc8d9c3d2abc547d0b</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_56c3dd1b18e078bc8d9c3d2abc547d0b</guid>
      <author>Tohme, Sara</author>
      <dc:format>masterThesis</dc:format>
      <dc:date>2023</dc:date>
      <dc:creator>Tohme, Sara</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Efficacy And Safety of Cannabidiol on Juvenile Diabetes Outcomes in Male Rats</title>
      <pubDate>Sun, 01 Jan 2023 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_be9afc667fcd4dc5f50116ebe8c3564f</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_be9afc667fcd4dc5f50116ebe8c3564f</guid>
      <author>Awkar, Nai</author>
      <dc:format>masterThesis</dc:format>
      <dc:date>2023</dc:date>
      <dc:creator>Awkar, Nai</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Bone-targeted therapies in metastatic castration-resistant prostate cancer</title>
      <pubDate>Tue, 01 Jan 2013 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_c3c77de1811529863b59309ef24120f0</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_c3c77de1811529863b59309ef24120f0</guid>
      <author>El-Amm, Joelle</author>
      <dc:format>article</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>El-Amm, Joelle</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression</title>
      <pubDate>Fri, 01 Jan 2021 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_51fb3c8d1d9f1bc76d5d7f90dc3c0155</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_51fb3c8d1d9f1bc76d5d7f90dc3c0155</guid>
      <author>Rayanah Barnawi (8737584)</author>
      <dc:date>2021</dc:date>
      <dc:creator>Rayanah Barnawi (8737584)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells</title>
      <pubDate>Tue, 01 Jan 2019 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_88e6374c6ac822bfd4d99501213f29a3</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_88e6374c6ac822bfd4d99501213f29a3</guid>
      <author>Nihal AlMuraikhi (6002234)</author>
      <dc:date>2019</dc:date>
      <dc:creator>Nihal AlMuraikhi (6002234)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Hedgehog Signaling Inhibition by Smoothened Antagonist BMS-833923 Reduces Osteoblast Differentiation and Ectopic Bone Formation of Human Skeletal (Mesenchymal) Stem Cells</title>
      <pubDate>Tue, 01 Jan 2019 18:19:59 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_902e5bfaf51dc9a73475399b9216b7b8</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_902e5bfaf51dc9a73475399b9216b7b8</guid>
      <author>Nihal AlMuraikhi (6002234)</author>
      <dc:date>2019</dc:date>
      <dc:creator>Nihal AlMuraikhi (6002234)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
